Researchers: Statin Users Risk Heart Attacks by Dropping Treatment or Taking Low Doses
Thousands of statin users worldwide are suffering preventable heart attacks, simply because they are not complying with their treatment or are taking too low a dose, according to new research.
Fructose-Sweetened Drinks Increase Nonfasting Triglycerides in Obese Adults
Obese people who drink fructose-sweetened beverages with their meals have an increased rise of triglycerides following the meal, according to new research.
Statin Drugs and Risk of Advanced Prostate Cancer
Statins are commonly prescribed agents to lower cholesterol and the associated risks of vascular events. Statins are also known to have proapoptotic and antimetastatic effects in cancer.
Eating Cholesterol-Lowering Foods Results in Bigger Decrease in LDL Than Low-Saturated-Fat Diet
Persons with high cholesterol who received counseling regarding a diet that combined cholesterol-lowering foods such as soy protein, nuts and plant sterols over 6 months experienced a greater reduction in their low-density lipoprotein cholesterol (LDL-C) levels than individuals who received advice on a low-saturated fat diet.
Eating Nuts Every Day Could Help Control Type 2 Diabetes and Even Prevent Complications
Eating nuts every day could help control Type 2 diabetes and prevent its complications, according to new research from St. Michael's Hospital and the University of Toronto.
Researchers Link Red Wine to Good Cholesterol
Researchers in France have found differences in red wine drinkers' good cholesterol, which could account for the drink's beneficial effects against cardiovascular disease.
Substance in Tangerines Fights Obesity and Protects Against Heart Disease
New research has discovered a substance in tangerines not only prevents obesity, but also offers protection against type 2 diabetes, and even atherosclerosis.
Study: Popular Cholesterol-Lowering Statin May Reduce the Benefits of Exercise
Researchers found that a widely used statin hindered the positive effects of exercise for obese and overweight adults.
Mixed Results For Weight Loss Drug on Slowing Progression of Coronary Disease
The anti-obesity medication rimonabant showed mixed results in slowing progression of coronary artery disease in patients with abdominal obesity and pre-existing coronary disease, according to a new study in the April 2 issue of JAMA.
Researchers Identify New Way To Reduce Cholesterol Levels
Just in time for the holidays, McGill researchers have identified a new way to reduce fat and cholesterol levels in the body.
Fish Oil and Red Yeast Rice Studied for Lowering Blood Cholesterol
Researchers examine whether an alternative approach to treating high blood cholesterol may provide an effective treatment option for patients who are unable or unwilling to take statins.
World’s Largest Cholesterol-Lowering Trial Reveals Massive Benefits for High-Risk Patients
Around a third of all heart attacks and strokes can be avoided in people at risk of vascular disease by using statin drugs to lower blood cholesterol levels – irrespective of the person’s age or sex, and even if their cholesterol levels do not seem high.
Higher Oxidized LDL Levels Linked to Increased Risk of Metabolic Syndrome
Higher concentrations of low-density lipoprotein (LDL) that has been modified by oxidation is associated with an increased incidence of abdominal obesity, high fasting glucose levels and high triglyceride levels and the metabolic syndrome, which includes a combination of these conditions.
Researcher Breaks Down Cholesterol Mystery
Scientist: chylomicrons gather on arterial walls and may be as dangerous or more dangerous than low-density lipoprotein (LDL) cholesterol in causing strokes and heart attacks.
Popular Cholesterol Drug Activates the Same Receptors as Medical Marijuana
New research in The FASEB Journal suggests that fenofibrate activates cannabinoid receptors and may become a viable treatment option for relieving pain, stimulating appetite,...
Effect of Lowering Blood Pressure and Cholesterol on Risk for Cognitive Decline in Diabetics
Intensive blood pressure and cholesterol lowering was not associated with reduced risk for diabetes-related cognitive decline in older patients with long-standing type 2 diabetes mellitus.




